Apricus Biosciencesincis A Biopharmaceutical Company Based In San Diegocaliforniaoriginally Focused On Urology And Rheumatologyit Transitioned To Central Nervous Systemcnstherapeutics Following Its Merger With Seelos Therapeutics In 2018Thecompany Is Known For Its Innovativetherapies And Has A History Of Developing Products For Various Medical Conditions Oneof Its Notableproducts Is Vitarosa An Approved Treatment For Erectiledysfunctionwhich Is Commercialized Through Partnerships With Companies Likemylan Nv And Takeda Pharmaceuticalsother Products Includefispemifenefor Malesecondary Hypogonadism And Rayvaa C For Raynaudaes Phenomenonpost Mergerthecompany Has Also Focused On Cns Related Treatmentsincluding Sls 002An Intranasal Ketaminefor Major Depressivedisorderand Sls 005An Iv Trehalosefor Als And Spinocerebellar Ataxiaapricus Continues To Leverageits Partnerships For Product Distribution Whileadvancing Its Pipelineunder Theseelos Therapeutics Brand
